ARCHIVES

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

January 28, 2005

Contracts Cutback Canceled 7 RFPs

August 8, 1980

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007

Sen. Edward Kennedy Receives ACS Medal

January 23, 2009

Trial Needed Of PSA To Determine Patients To Test, Chabner Says

March 5, 1993